Strata Skin Sciences, Inc.
SSKN
$1.79
-$0.03-1.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.36% | 3.30% | 0.61% | -7.36% | -8.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.36% | 3.30% | 0.61% | -7.36% | -8.66% |
| Cost of Revenue | -7.29% | -9.49% | -3.06% | -1.71% | 3.03% |
| Gross Profit | 6.77% | 14.78% | 3.58% | -11.42% | -16.58% |
| SG&A Expenses | 12.60% | 4.16% | 0.72% | -3.61% | -13.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.24% | -2.62% | -1.82% | -3.57% | -7.69% |
| Operating Income | -21.59% | 31.75% | 14.65% | -22.99% | 1.02% |
| Income Before Tax | -39.31% | 18.64% | 6.10% | -32.83% | -18.81% |
| Income Tax Expenses | -84.78% | -84.78% | -84.78% | -246.03% | -246.03% |
| Earnings from Continuing Operations | -38.80% | 19.48% | 6.87% | -30.39% | -16.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.80% | 19.48% | 6.87% | -30.39% | -16.48% |
| EBIT | -21.59% | 31.75% | 14.65% | -22.99% | 1.02% |
| EBITDA | -1,788.75% | 134.40% | 44.46% | -306.00% | -68.99% |
| EPS Basic | -17.23% | 31.83% | 16.41% | -25.88% | -15.88% |
| Normalized Basic EPS | 4.82% | 33.25% | 11.76% | -24.29% | -12.69% |
| EPS Diluted | -17.23% | 31.83% | 16.41% | -25.88% | -15.88% |
| Normalized Diluted EPS | 4.82% | 33.25% | 11.76% | -24.29% | -12.69% |
| Average Basic Shares Outstanding | 18.20% | 13.60% | 9.00% | 4.42% | 0.62% |
| Average Diluted Shares Outstanding | 18.20% | 13.60% | 9.00% | 4.42% | 0.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |